Growing Interest in Cancer and Stem Cell Research to Boost the Cell Culture Reagents Market

Growing Interest in Cancer and Stem Cell Research to Boost the Cell Culture Reagents Market

[Redding, California], a leading provider of innovative solutions in the biotechnology sector, anticipates a robust expansion in the global Cell Culture Reagents Market. Projections suggest that by 2029, the market is poised to exceed $11.04 billion, reflecting a notable Compound Annual Growth Rate (CAGR) of 12.8% spanning the period from 2022 to 2029.

Download Sample Copy: https://www.meticulousresearch.com/download-sample-report/cp_id=5322

Top Competitors interested in Cell Culture Reagents Market

The key players profiled in the cell culture reagents market study are Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), PromoCell GmbH (Germany), Cytiva (U.S.), Lonza Group Ltd (Switzerland), Corning Incorporated (U.S.), Becton, Dickinson and Company (U.S.), HiMedia Laboratories (India), Sartorius AG (Germany), FUJIFILM Holdings Corporation (Japan), Agilent Technologies, Inc. (U.S.), Miltenyi Biotec B.V. & Co. KG (Germany), BIOLOGOS (U.S.), STEMCELL Technologies Inc. (Canada), and Cell Applications, Inc. (U.S.).

Asia-Pacific: Fastest-growing Regional Market

Based on geography, Asia-Pacific is expected to register the highest CAGR during the forecast period. The growing population is the key factor that drives this region's healthcare & pharmaceutical sector, which draws a lot of investment from government & non-government bodies. Asia-Pacific countries aim to become competitive in the global biotech market, paving the way for a lot of research & development activities in this domain. Additionally, the increasing investments propel the demand for cell culture reagents across the Asia-Pacific region.

Speak to Analyst For Any Enquiry: https://www.meticulousresearch.com/enquire-before-buying/cp_id=5322

Cancer cases are rising globally due to changes in the living lifestyle of the people. It is one of the major health concerns globally. According to GLOBOCAN, the number of new cancer cases is estimated to reach 24,044,406 in 2030 from 19,292,789 in 2020. To tackle this, extensive research studies help to gain knowledge about the biological processes involved in the body's onset, growth and spread of cancer. The study data and analysis of the results help prevent, diagnose, diagnose, and treat cancer at earlier stages. These ongoing research studies are aimed at advancing earlier discoveries and observations. Cell culture plays an important role in the basic cancer research for growing the cancer cells in different culture environments and in the presence of various chemicals to study their effect on cancerous cells.

Moreover, funding to support these research studies positively impacts the market. For instance, the National Cancer Institute (NCI) (U.S.) invests in a broad cancer research portfolio, from basic science to survivorship. According to their Annual Plan & Budget Proposal for Fiscal Year 2023 report, it is proposed that the NCI Research Project Grants will increase from USD 3.1 billion in 2022 to USD 4.2 billion by 2025.

Check Discount Price: https://www.meticulousresearch.com/request-discount/cp_id=5322

Similarly, stem cells and cell lines are being used for the functional restoration of damaged tissues using tissue engineering and stem cell research. The ability of indefinite self-renewal and the potential to differentiate into any cell type makes stem cells most suitable for research. At present, donated tissues and organs cannot meet the transplantation demands of the diseased population because of the inability to differentiate into any cell type. Thus, animal cell culture is emerging as a new opportunity to repair tissue and organ anomalies due to congenital defects, disease, and age-associated effects. It was found that embryonic stem cells (ESC) can give rise to 200 types of cells and promise the treatment of any disease. This is because of the presence of pluripotency factors in the cells.

In the case of cardiovascular diseases, biomedical therapeutics help immediately restore heart functions. The regeneration of cardiac tissue can achieve this through ESCs-derived cardiovascular progenitors and bone marrow-derived mononuclear cells (BMDMNCs). Other stem cells, such as mesenchymal, umbilical cord, induced pluripotent, and bone marrow, are also used in regenerative medicine. In the past few decades, regenerative medicines have emerged in China and other countries like the U.S., Europe, Japan, and Singapore. Thus, stem cells can be used in regenerative medicine with their unique property of regeneration and self-renewal during structural or functional injury, thereby expanding stem cell research activities.

Additionally, the availability of funding to support stem cell research studies will further lead to increased demand for cell culture products. For instance, The Morrison Government boosted stem cell research in Australia by providing grants of USD 25 million, which will be available over five years from 2021-22, through two funding streams. In stream 1, up to USD 15 million will be used to support the development of novel stem-cell-based treatments. In stream 2, up to USD 10 million will be used to support large-scale projects focusing on pre-clinical evaluation and screening of new treatments. The research will use human tissues from stem cells involving large-scale multi-disciplinary teams.

Buy This Report: https://www.meticulousresearch.com/Checkout/16522482

Cell Culture Reagents Market, by End User

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

Diagnostic Laboratories

About Us:
We are the trusted research partners for leading businesses around the world, providing market intelligence focused towards building revenue transformation strategies. Our research is used by Fortune 500 organizations to attain success by scouting next generation revenue opportunities well ahead of their competition.

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

This release was published on openPR.